*Corresponding author:
Goichi Matsumoto, Department of Oral and Maxillofacial Surgery, Kanazawa Medical University. 1-1 Daigaku, Uchinada, Kahoku-gunn, Ishikawa 920-0293, JapanReceived: April 23, 2018; Published: May 02,2018
DOI: 10.26717/BJSTR.2018.04.001025
To view the Full Article Peer-reviewed Article PDF
We report here the clinical effects of the sustained release of basic fibroblast growth factor (bFGF) from gelatin hydrogel in cases of periodontal disease with infrabony defects. Patients with moderate to advanced periodontitis were treated with a mucoperiosteal flap operation. At the time of surgery, each bone defect was filled with gelatin hydrogel incorporating bFGF (bFGF/gelatin hydrogel). Probing pocket depth (PPD), clinical attachment level (CAL), and radiographic bone level were evaluated before treatment and at 3, 6, and 12 months after treatment. There were significant improvements in clinical parameters after treatment. There were no adverse effects during the treatment period. Topical application of bFGF/gelatin hydrogel may promote periodontal regeneration in cases of chronic periodontitis with infrabony defects.
Keywords: BFGF; Gelatin Hydrogel; DDS; Regeneration; Infrabony Defects; Periodontitis; Clinical Trial
Abstract| Introduction| Material and Methods| Results| Discussion| Conclusion| References|